Bioavailability Enhancement Technologies
February 28, 2023 ⚊ 1 Min read ⚊ Views 61 ⚊ HEALTHA study conducted on terminated drug development projects revealed that majority of the drug candidates fail in early drug development phases, due to the problems associated with their pharmacokinetic profiles, ADME properties and toxicity-related issues.
Tags: bioavailability, Bioavailability Technologies